Showing results (1191-1200 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1995
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group studyS Baruchel, M Bernstein, V M Whitehead, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancerN B Haas, R J Schilder, S Nash, et al.
Investigational New Drugs|January 1, 1996
A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group studyJ R Geyer, F M Balis, M D Krailo, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group studyT R Fleming, T D Brown, S W Ross, et al.
Investigational New Drugs|November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitorsPierre Loulergue, Mansouria Merad, Romain Coriat, et al.
Investigational New Drugs|November 23, 2016
Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumorsLuis Paz-Ares, Martin Forster, Valentina Boni, et al.
Investigational New Drugs|November 18, 2016
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancersLaura W Goff, Dana B Cardin, Jennifer G Whisenant, et al.
Investigational New Drugs|July 1, 1989
Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumorsC B Pratt, E C Douglass, W H Meyer, et al.
Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
Investigational New Drugs|January 16, 2008
A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)Jennifer J Knox, Sharlene Gill, Timothy W Synold, et al.
Pageof 372